QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online March 5, 2008
doi: 10.1242/10.1242/jcs.026096

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bovolenta, P. Articles by Lopez-Rios, J. Search for Related Content PubMed PubMed Citation Articles by Bovolenta, P. Articles by Lopez-Rios, J. Social Bookmarking                         What's this?

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

¹ Departamento de Neurobiología Molecular, Celular y del Desarrollo, Instituto Cajal, CSIC, Dr Arce 37, Madrid 28002, Spain
² Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Instituto de Salud Carlos III, Madrid, Spain

^* Author for correspondence (e-mail: bovolenta{at}cajal.csic.es)

Accepted 28 January 2008

The secreted Frizzled-related proteins (SFRPs) are a family of soluble proteins that are structurally related to Frizzled (Fz) proteins, the serpentine receptors that mediate the extensively used cell-cell communication pathway involving Wnt signalling. Because of their homology with the Wnt-binding domain on the Fz receptors, SFRPs were immediately characterised as antagonists that bind to Wnt proteins to prevent signal activation. Since these initial studies, interest in the family of SFRPs has grown progressively, offering new perspectives on their function and mechanism of action in both development and disease. These studies indicate that SFRPs are not merely Wnt-binding proteins, but can also antagonise one another's activity, bind to Fz receptors and influence axon guidance, interfere with BMP signalling by acting as proteinase inhibitors, and interact with other receptors or matrix molecules. Furthermore, their expression is altered in different types of cancers, bone pathologies, retinal degeneration and hypophosphatemic diseases, indicating that their activity is fundamental for tissue homeostasis. Here we review some of the debated aspects of SFRP-Wnt interactions and discuss the new and emerging roles of SFRPs.

Key words: Bmp, Signalling antagonists, Cancer, Diseases

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. S. Torday and V. K. Rehan Lung evolution as a cipher for physiology Physiol Genomics, June 1, 2009; 38(1): 1 - 6. [Abstract] [Full Text] [PDF]

				A. J. G. Dickinson and H. L. Sive The Wnt antagonists Frzb-1 and Crescent locally regulate basement membrane dissolution in the developing primary mouth Development, April 1, 2009; 136(7): 1071 - 1081. [Abstract] [Full Text] [PDF]